Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies
- PMID: 15695799
Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies
Abstract
We present a method to measure the regional rate of cellular proliferation using a positron-emitting analog of thymidine (TdR) for human imaging studies. The method is based on the use of 3'-deoxy-3'-(18)F-fluorothymidine (FLT) to estimate the flux of TdR through the exogenous pathway. The model reflects the retention of FLT-monophosphate (FLTMP), which is generated by the phosphorylation of FLT by thymidine kinase 1 (TK1), the initial step in the exogenous pathway.
Methods: A model of FLT kinetics has been designed based on the assumptions of a steady-state synthesis and incorporation of nucleotides into DNA, an equilibration of the free nucleoside in tissue with the plasma level, and the relative rates of FLT and TdR phosphorylation from prior data using direct analysis with in vitro assays. A 2-compartment model with 4 rate constants adequately describes the kinetics of FLT uptake and retention over 120 min and leads to an estimation of the rate of cellular proliferation using the measured FLT blood clearance and the dynamic FLT uptake curve.
Results: Noise characteristics of kinetic parameter estimates for 3 tissues were assessed under a range of conditions representative of human cancer patient imaging. The FLT flux in these tissues can be measured with a SE of <5%, and FLT transport can be estimated with a SE of <15%. Abbreviating the data collection to 60 min or neglecting k(4), giving a 3-parameter model, results in an unsatisfactory loss of accuracy in the flux constant in tumor simulations.
Conclusion: These analyses depict model behavior and provide expected values for the accuracy of parameter estimates from FLT imaging in human patients. Our companion paper describes the performance of the model for human data in patients with lung cancer. Further studies are necessary to determine the fidelity of K(FLT) (FLT flux) as a proxy for K(TDR) (thymidine flux), the gold standard for imaging cellular proliferation.
Comment in
-
Kinetic analysis of 18F-FLT PET in lung tumors.J Nucl Med. 2012 Mar;53(3):506; author reply 506-507. doi: 10.2967/jnumed.111.097816. Epub 2012 Jan 31. J Nucl Med. 2012. PMID: 22294484 No abstract available.
Similar articles
-
Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.J Nucl Med. 2005 Feb;46(2):274-82. J Nucl Med. 2005. PMID: 15695787 Clinical Trial.
-
Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice.J Nucl Med. 2008 Dec;49(12):2057-66. doi: 10.2967/jnumed.108.053215. Epub 2008 Nov 7. J Nucl Med. 2008. PMID: 18997037
-
Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.J Nucl Med. 2006 Oct;47(10):1612-21. J Nucl Med. 2006. PMID: 17015896
-
Applications of PET imaging with the proliferation marker [18F]-FLT.Q J Nucl Med Mol Imaging. 2015 Mar;59(1):95-104. Epub 2015 Mar 4. Q J Nucl Med Mol Imaging. 2015. PMID: 25737423 Free PMC article. Review.
-
Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation.Nucl Med Commun. 2009 Dec;30(12):908-17. doi: 10.1097/MNM.0b013e32832ee93b. Nucl Med Commun. 2009. PMID: 19794320 Review.
Cited by
-
Limits of [18F]-FLT PET as a biomarker of proliferation in oncology.PLoS One. 2013;8(3):e58938. doi: 10.1371/journal.pone.0058938. Epub 2013 Mar 15. PLoS One. 2013. PMID: 23554961 Free PMC article.
-
Methodological considerations in quantification of 3'-deoxy-3'-[18F]fluorothymidine uptake measured with positron emission tomography in patients with non-small cell lung cancer.Mol Imaging Biol. 2014 Feb;16(1):136-45. doi: 10.1007/s11307-013-0658-3. Mol Imaging Biol. 2014. PMID: 23813332 Clinical Trial.
-
Kinetic analysis of 18F-fluoride PET images of breast cancer bone metastases.J Nucl Med. 2010 Apr;51(4):521-7. doi: 10.2967/jnumed.109.070052. Epub 2010 Mar 17. J Nucl Med. 2010. PMID: 20237040 Free PMC article. Clinical Trial.
-
Evaluation of limited blood sampling population input approaches for kinetic quantification of [18F]fluorothymidine PET data.EJNMMI Res. 2012 Mar 24;2:11. doi: 10.1186/2191-219X-2-11. EJNMMI Res. 2012. PMID: 22444834 Free PMC article.
-
Heterogeneity in stabilization phenomena in FLT PET images of canines.Phys Med Biol. 2014 Dec 21;59(24):7937-55. doi: 10.1088/0031-9155/59/24/7937. Epub 2014 Nov 26. Phys Med Biol. 2014. PMID: 26009642 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources